Evolutionary Genomics Competitors and Similar CompaniesClear all
Caribou Biosciences's competitors and similar companies include Editas Medicine.
 Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company. |  Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. | |
Founding Date | Founding Date 2012 | Founding Date 2013 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Berkeley, US HQ | Locations Cambridge, US HQ Boulder, US Cambridge, US |
Employees | Employees 1477% decrease | Employees 20816% increase |
Valuation ($) | Valuation ($) 174.4 m | Valuation ($) 256.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) $11.2m (FY, 2025) | Revenue (est.) $40.5m (FY, 2025) |
Net income | Net income ($148.1m) (FY, 2025) | Net income ($160.1m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 159.5m | Total funding raised $ 210m |
For sources of this data, please see the company profile
View Company Profiles
Editas Medicine
HQ
Cambridge, US
Employees
208↑ 16% increase
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
View company